Home Cart 0 Sign in  
X

[ CAS No. 84341-13-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 84341-13-9
Chemical Structure| 84341-13-9
Chemical Structure| 84341-13-9
Structure of 84341-13-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 84341-13-9 ]

Related Doc. of [ 84341-13-9 ]

Alternatived Products of [ 84341-13-9 ]

Product Details of [ 84341-13-9 ]

CAS No. :84341-13-9 MDL No. :MFCD29059302
Formula : C7H4ClN3O Boiling Point : -
Linear Structure Formula :- InChI Key :BUERZTTWXDSSIY-UHFFFAOYSA-N
M.W : 181.58 Pubchem ID :135741643
Synonyms :

Calculated chemistry of [ 84341-13-9 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 44.37
TPSA : 58.9 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.45
Log Po/w (XLOGP3) : 1.41
Log Po/w (WLOGP) : 1.38
Log Po/w (MLOGP) : 0.49
Log Po/w (SILICOS-IT) : 1.61
Consensus Log Po/w : 1.27

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.47
Solubility : 0.614 mg/ml ; 0.00338 mol/l
Class : Soluble
Log S (Ali) : -2.25
Solubility : 1.02 mg/ml ; 0.00561 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.0
Solubility : 0.183 mg/ml ; 0.00101 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.69

Safety of [ 84341-13-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 84341-13-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 84341-13-9 ]
  • Downstream synthetic route of [ 84341-13-9 ]

[ 84341-13-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 122-51-0 ]
  • [ 84341-13-9 ]
YieldReaction ConditionsOperation in experiment
97% for 18 h; Reflux A mixture of 3-amino-2-chloropyridine-4-carboxamide (500 mg, 2.9 mmol) in 5 mL of triethyl orthoformate was stirred at reflux for 18 h. The reaction mixture was concentrated and triturated with hexanes. Solid filtered and dried to give the title compound as a tan solid (510 mg, 97percent). ‘H NMR (400 MHz, DMSO-d6): ö 7.96 (1H, d, J 5.1 Hz), 8.30 (1H, s), 8.44 (1H, d, J 5.2 Hz), 12.85(1H, br s). [M+H] Calc’d for C7H4C1N3O, 182;Found, 182.
Reference: [1] Patent: WO2014/151106, 2014, A1, . Location in patent: Paragraph 00350
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 4, p. 1388 - 1409
  • 2
  • [ 6298-19-7 ]
  • [ 84341-13-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5923 - 5930
  • 3
  • [ 209798-48-1 ]
  • [ 84341-13-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5923 - 5930
  • 4
  • [ 1312105-89-7 ]
  • [ 84341-13-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5923 - 5930
  • 5
  • [ 58483-94-6 ]
  • [ 84341-13-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 4, p. 1388 - 1409
  • 6
  • [ 58483-94-6 ]
  • [ 77287-34-4 ]
  • [ 84341-13-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5923 - 5930
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 84341-13-9 ]

Chlorides

Chemical Structure| 101494-95-5

[ 101494-95-5 ]

8-Chloroquinazolin-4-ol

Similarity: 0.71

Chemical Structure| 16064-14-5

[ 16064-14-5 ]

6-Chloroquinazolin-4-ol

Similarity: 0.65

Chemical Structure| 960299-06-3

[ 960299-06-3 ]

4-Chloro-6-methoxy-5-methylpyrimidine

Similarity: 0.60

Chemical Structure| 202273-25-4

[ 202273-25-4 ]

6-Chloropyrido[3,4-d]pyrimidine

Similarity: 0.59

Chemical Structure| 1373333-62-0

[ 1373333-62-0 ]

7-Chloro-2-methyl-2H-pyrazolo[3,4-c]pyridine

Similarity: 0.58

Alcohols

Chemical Structure| 101494-95-5

[ 101494-95-5 ]

8-Chloroquinazolin-4-ol

Similarity: 0.71

Chemical Structure| 16064-14-5

[ 16064-14-5 ]

6-Chloroquinazolin-4-ol

Similarity: 0.65

Chemical Structure| 1769-24-0

[ 1769-24-0 ]

2-Methylquinazolin-4-ol

Similarity: 0.64

Chemical Structure| 19178-21-3

[ 19178-21-3 ]

2-Methyl-5,6,7,8-tetrahydroquinazolin-4-ol

Similarity: 0.62

Chemical Structure| 19181-64-7

[ 19181-64-7 ]

6-Methoxyquinazolin-4-ol

Similarity: 0.60

Related Parent Nucleus of
[ 84341-13-9 ]

Other Aromatic Heterocycles

Chemical Structure| 19178-21-3

[ 19178-21-3 ]

2-Methyl-5,6,7,8-tetrahydroquinazolin-4-ol

Similarity: 0.62

Chemical Structure| 202273-25-4

[ 202273-25-4 ]

6-Chloropyrido[3,4-d]pyrimidine

Similarity: 0.59

Chemical Structure| 1373333-62-0

[ 1373333-62-0 ]

7-Chloro-2-methyl-2H-pyrazolo[3,4-c]pyridine

Similarity: 0.58

Chemical Structure| 1187830-77-8

[ 1187830-77-8 ]

4-Methoxy-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine hydrochloride

Similarity: 0.56

Chemical Structure| 1618-36-6

[ 1618-36-6 ]

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.54